首页> 外文期刊>Gastroenterology research and practice >Is Occult Obscure Gastrointestinal Bleeding a Definite Indication for Capsule Endoscopy? A Retrospective Analysis of Diagnostic Yield in Patients with Occult versus Overt Bleeding
【24h】

Is Occult Obscure Gastrointestinal Bleeding a Definite Indication for Capsule Endoscopy? A Retrospective Analysis of Diagnostic Yield in Patients with Occult versus Overt Bleeding

机译:隐匿性胃肠道出血是胶囊内镜检查的明确指征吗?隐匿性出血与显性出血患者诊断率的回顾性分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background/Aim. Usefulness of capsule endoscopy (CE) for diagnosing small-bowel lesions in patients with obscure gastrointestinal bleeding (OGIB) has been reported. Most reports have addressed the clinical features of overt OGIB, with few addressing occult OGIB. We aimed to clarify whether occult OGIB is a definite indication for CE. Methods. We retrospectively compared the cases of 102 patients with occult OGIB and 325 patients with overt OGIB, all having undergone CE. The diagnostic yield of CE and identification of various lesion types were determined in cases of occult OGIB versus overt OGIB. Results. There was no significant difference in diagnostic yield between occult and overt OGIB. The small-bowel lesions in cases of occult OGIB were diagnosed as ulcer/erosive lesions (n = 18,18%), vascular lesions (n = 11,11%), and tumors (n = 4, 3%), and those in cases of overt OGIB were diagnosed as ulcer/erosive lesions (n = 51,16%), vascular lesions (n = 31,10%), and tumors (n = 20, 6%). Conclusion. CE detection rates and CE identification of various small-bowel diseases do not differ between patients with occult versus overt OGIB. CE should be actively performed for patients with either occult or overt OGIB.
机译:背景/目标。胶囊内窥镜检查(CE)在消化道出血(OGIB)患者诊断小肠病变中的有用性已有报道。大多数报告都针对明显的OGIB的临床特征,很少涉及隐匿性OGIB。我们旨在澄清隐匿性OGIB是否是CE的明确指征。方法。我们回顾性比较了102例隐匿性OGIB患者和325例明显的OGIB患者,他们均接受了CE治疗。在隐匿性OGIB与明显OGIB的情况下,确定了CE的诊断率和各种病变类型的鉴定。结果。隐匿性和明显的OGIB之间的诊断产率没有显着差异。在隐匿性OGIB病例中,小肠病变被诊断为溃疡/糜烂性病变(n = 18,18%),血管病变(n = 11,11%)和肿瘤(n = 4,3%),以及在明显的OGIB病例中,被诊断为溃疡/糜烂性病变(n = 51.16%),血管病变(n = 31.10%)和肿瘤(n = 20、6%)。结论。隐匿性和明显性OGIB患者之间的各种小肠疾病的CE检测率和CE鉴定没有差异。对于隐匿性或明显OGIB的患者,应积极进行CE。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号